Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 147 - Health
Type: Contributed
Date/Time: Monday, August 8, 2022 : 10:30 AM to 12:20 PM
Sponsor: Government Statistics Section
Abstract #323084
Title: Improving Efficacy Estimates for New HIV Antivirus Pre-Clinical Studies: A Simulation Study
Author(s): Yi Pan*
Companies: Centers for Disease Control and Prevention (CDC)
Keywords: Efficacy; HIV Pre-clinical Studies; Repeated measurements; Risk Ratio
Abstract:

In many preclinical HIV prevention studies, efficacy is typically calculated as one minus the risk ratio (RR). The standard estimation methods used in these studies ignores (1) the time-to-event nature of the data; or (2) possible heterogeneity in susceptibility across animals; or (3) possible carry-over effect of prior challenges on the risk of infection during current challenge. In this study, we compared five different methods of measuring efficacy: 1) estimating the RR from a single, final binary outcome per subject; 2) a logistic model for sequences of challenges, assuming homogeneous risk across subjects and challenges; 3) GEE or a random effects logistic model that accounts for between-subject heterogeneity but not time heterogeneity; 4) a conditional logistic regression; and 5) a frailty Cox proportional hazards model to accommodate both between-subject and time heterogeneity. Our simulation results indicated that the model-based methods were robust compared to methods (1) and (2). Especially, the conditional logistic regression and the HR approach generated smaller biases and standard errors compared to GEE method.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program